胺碘酮治疗充血性心力衰竭合并室性心律失常137例临床分析

目的：评价使用胺碘酮治疗充血性心力衰竭合并室性心律失常患者的临床疗效和安全性。方法：选择2008年3月至2012年6月入住我院内科、ICU，诊断为充血性心力衰竭且合并有室性心律失常的患者137例，静脉、口服胺碘酮序贯治疗8周并评价临床疗效。，结果：使用胺碘酮治疗24h后90例患者显效，有效率达66％；治疗48h后119例患者病情明显好转，有效率达87％；治疗72h后133例患者病情得到良好控制，有效率达97％。结论：临床上采用胺碘酮治疗充血性心力衰竭合并室性心律失常安全有效。

Clinical Analysis of Intravenous Amiodarone in Treating 137 CHF Patients Combined with Ventricular Arrhythmia

Objective： To evaluate the clinical efficiency and safety of intrawnous amiodarone in trearing patients with congestive heart failure and malignant ventricular arrhythmia. Method： 137 patients who were enrolled in the departments of emergency or cardiology of our hospital and diagnosed as congestive heart failure and malignant ventricular arrhythmia were chosen to take part in this clinical trial. All of the patients were given amiodarone for eight weeks to evaluate the were excellent after 24 hours of treatment and by the patients （87 % ） were much better. At the end of 72 efficiency and safety. Result： end of 48 hour＇ treatment, o hours of treatment, one hund Ninety patients （66 % ）ne hundred and nineteen red and thirty-three （97% ） patients＇ illnesses were well managed. Conclusion： Intravenous amiodarone has a high clinical efficiency and it＇s safe in curing the patients with congestive heart failure and malignant ventricular arrhythmia.